Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.

MLA

Marchiq, Ibtissam, and Jacques Pouysségur. “Hypoxia, Cancer Metabolism and the Therapeutic Benefit of Targeting Lactate/H(+) Symporters.” Journal of Molecular Medicine (Berlin, Germany), vol. 94, no. 2, Feb. 2016, pp. 155–71. EBSCOhost, https://doi.org/10.1007/s00109-015-1307-x.

APA

Marchiq, I., & Pouysségur, J. (2016). Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters. Journal of Molecular Medicine (Berlin, Germany), 94(2), 155–171. https://doi.org/10.1007/s00109-015-1307-x

Chicago

Marchiq, Ibtissam, and Jacques Pouysségur. 2016. “Hypoxia, Cancer Metabolism and the Therapeutic Benefit of Targeting Lactate/H(+) Symporters.” Journal of Molecular Medicine (Berlin, Germany) 94 (2): 155–71. doi:10.1007/s00109-015-1307-x.